Invited Review: Decoding the pathophysiological mechanisms that underlie RNA dysregulation in neurodegenerative disorders: a review of the current state of the art
Year: 2015
Type: review
Abstract: Altered RNA metabolism is a key pathophysiological component causing several neurodegenerative diseases. Genetic mutations causing neurodegeneration occur in coding and noncoding regions of seemingly unrelated genes whose products do not always contribute to the gene expression process. Several pathogenic mechanisms may coexist within a single neuronal cell, including RNA/protein toxic gain-of-function and/or protein loss-of-function. Genetic mutations that cause neurodegenerative disorders disrupt healthy gene expression at diverse levels, from chromatin remodelling, transcription, splicing, through to axonal transport and repeat-associated non-ATG (RAN) translation. We address neurodegeneration in repeat expansion disorders [Huntington's disease, spinocerebellar ataxias, C9ORF72-related amyotrophic lateral sclerosis (ALS)] and in diseases caused by deletions or point mutations (spinal muscular atrophy, most subtypes of familial ALS). Some neurodegenerative disorders exhibit broad dysregulation of gene expression with the synthesis of hundreds to thousands of abnormal messenger RNA (mRNA) molecules. However, the number and identity of aberrant mRNAs that are translated into proteins - and how these lead to neurodegeneration - remain unknown. The field of RNA biology research faces the challenge of identifying pathophysiological events of dysregulated gene expression. In conclusion, we discuss current research limitations and future directions to improve our characterization of pathological mechanisms that trigger disease onset and progression.
DOI: 10.1111/nan.12187
Authors: Matthew J. Walsh, Johnathan Cooper‐Knock, Jennifer E. Dodd, Matthew J. Stopford, Simeon R. Mihaylov, Janine Kirby, Pamela J. Shaw, Guillaume M. Hautbergue
Institution: University of Sheffield
Language: English
Subfield: Clinical Neurology
Field: Medicine
Domain: Health Sciences
Keywords: neurodegenerative diseases, repeat expansion disorders, Huntington's disease, spinocerebellar ataxia, C9orf72, amyotrophic lateral sclerosis, spinal muscular atrophy, familial ALS, repeat-associated non-ATG translation, chromatin remodeling, transcription, RNA splicing, axonal transport, gain-of-function toxicity, point mutations, gene deletion
Open Access status: hybrid
Estimated APC paid: $4,480
Awards: Characterisation of biological pathways dysregulated in amyotrophic lateral sclerosis (ALS) cases with a hexanucleotide repeat expansion of C9ORF72., G3207356259, G393177772, G5702163051, NIHR Senior Investigator Award, European multidisciplinary ALS network identification to cure motor neuron degeneration, Sampling and biomarker OPtimisation and Harmonisation In ALS and other motor neuron diseases (SOPHIA)
OpenAlex ID: W2140201042
